Three Asparagine insertions in the K13-propeller led to Plasmodium falciparum becoming resistant to multiple antimalaria drugs

 

1. Introduction

Malaria remains a significant global health burden, with Plasmodium falciparum as the most lethal parasite species causing severe and often fatal disease. The emergence of drug resistance, especially against artemisinin and its derivatives, has threatened control and eradication efforts. Molecular markers that can detect resistance early are crucial for improving treatment strategies. The Kelch 13 (K13) gene has been a primary focus due to its established association with artemisinin resistance. In this study, advanced CRISPR/Cas9 genome-editing technology was employed to investigate how specific insertions in the K13 gene affect drug sensitivity and parasite development, offering insights into new resistance mechanisms.

2. Application of CRISPR/Cas9 Technology in Genetic Modification of P. falciparum

The application of CRISPR/Cas9 has revolutionized malaria research by allowing precise, targeted modifications within the parasite genome. In this study, CRISPR/Cas9 was utilized to insert one, two, or three asparagine residues immediately after the 142nd amino acid in the K13 gene of the P. falciparum 3D7 strain. This precision editing generated three distinct strains—1N-3D7, 2N-3D7, and 3N-3D7—enabling controlled exploration of how incremental genetic modifications impact parasite behavior, drug resistance, and fitness.

3. Influence of Asparagine Insertions on Ring-Stage Survival Assay Outcomes

The Ring-Stage Survival Assay (RSA) is a pivotal tool for detecting artemisinin resistance in P. falciparum. Analysis revealed that inserting asparagine residues into the K13 gene resulted in a direct increase in RSA values, correlating the number of inserted residues with enhanced survival under drug pressure. Notably, 3N-3D7 demonstrated the highest RSA values, indicating that multiple insertions significantly strengthen the parasite's resistance profile during the critical early ring stages, which are primarily targeted by artemisinin derivatives.

4. Comparative Drug Sensitivity Profiles among Modified Strains

Drug sensitivity testing across ten antimalarial compounds highlighted important differences among the genetically modified strains. 1N-3D7 and 2N-3D7 showed similar IC50 values and exhibited resistance specifically to Naphthoquine, suggesting that single or double asparagine insertions confer comparable levels of resistance. However, 3N-3D7 exhibited notably higher IC50 values against five drugs—Artesunate, Artemether, Dihydroartemisinin, Pyronaridine Phosphate, and Naphthoquine—demonstrating a broader and more potent drug-resistant phenotype, confirming the critical impact of the triple insertion.

5. Impact of Triple Asparagine Insertion on Parasite Developmental Dynamics

Further investigations into the parasite's life cycle indicated that 3N-3D7 parasites experienced significant developmental alterations within red blood cells. The ring stage was prolonged, whereas the trophozoite phase was shortened. Although schizont development remained synchronous with the wild-type, mature schizonts in the 3N-3D7 strain contained fewer merozoites. These developmental changes suggest a complex adaptive response to the stress of drug exposure, possibly linked to the observed fitness costs.

6. Fitness Costs Associated with Enhanced Drug Resistance

Despite its increased drug resistance, the 3N-3D7 strain suffered a measurable fitness cost when co-cultured with the wild-type 3D7 strain. The proportion of 3N-3D7 parasites declined steadily, and the calculated fitness cost was approximately 14.88±2.87. These findings underscore a critical trade-off in P. falciparum: while genetic modifications can confer survival advantages under drug pressure, they may simultaneously impair overall parasite fitness and competitiveness in drug-free environments. This duality offers important insights for developing sustainable malaria control strategies.

Visit: https://infectious-diseases-conferences.pencis.com
Nominate Now: https://jut.li/XWmUe

Hashtags

#PlasmodiumFalciparum #MalariaResearch #DrugResistance #Kelch13 #CRISPRCas9 #GenomeEditing #ArtemisininResistance #RingStageSurvivalAssay #MalariaTreatment #GeneticMarkers #AntimalarialDrugs #ParasiteFitness #MalariaEradication #DrugSensitivity #PfalciparumGenetics #MalariaDrugDevelopment #MolecularParasitology #MalariaControl #PyronaridinePhosphate #NaphthoquineResistance